Sort
10,829 grants matching “car t”
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
$1,182,811Steven Mark Albelda · University Of Pennsylvania · P01 · FY2016 · CA
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
$1,182,811Steven Mark Albelda · University Of Pennsylvania · P01 · FY2012 · CA
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
$1,182,811Steven Mark Albelda · University Of Pennsylvania · P01 · FY2015 · CA
ENHANCEMENT OF IMMUNE CHECKPOINT BLOCKADE RESPONSIVENESS AND TERTIARY LYMPHOID STRUCTURE FORMATION THROUGH CD4+TFHX13 CAR-T CELLS TO ACHIEVE CCRCC CURES.
$1,181,683Dana-Farber Cancer Institute, Inc. · · FY2024 · Defense Health Agency
Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics
$1,180,225Michael M Binkley · Opencell Technologies, Inc. · R44 · FY2022 · CA
Resource for Molecular Imaging Agents in Precision Medicine
$1,179,527Martin G Pomper · Johns Hopkins University · P41 · FY2021 · EB
Xbeads: A Platform for Flow Cytometry Sample QC and Harmonization
$1,178,776Peter Krutzik · Cytorum, Inc. · R44 · FY2025 · GM
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,177,923Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
ASSESSMENT OF ENDOGENOUS AND CAR T-CELL IMMUNITY FOLLOWING ANTI-PD-1 AGENT AS A TRANSITION STEP TO PHASE 2 COMBINATION IMMUNOTHERAPY
$1,177,565Sloan-Kettering Institute For Cancer Research · · FY2019 · Department of the Army
SHF: Medium: More Reliable Image Networks through Scene-based Specification, Neuro-symbolic Training, and Systematic Specification-driven Testing
$1,174,741Sebastian G Elbaum · University Of Virginia Main Campus · · FY2023 · CSE
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs
$1,173,678Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
TWC: Medium: Designing Strongly Obfuscated Hardware with Quantifiable Security against Reverse Engineering
$1,170,727Christof Paar · University Of Massachusetts Amherst · · FY2016 · CSE
Programming T Cell Fates for Therapeutic Use
$1,166,116Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Center for Smart Use of Technology to Assess Real-world Outcomes (C-STAR)
$1,164,643Richard L Lieber · Rehabilitation Institute Of Chicago D/B/A Shirley Ryan Abilitylab · P2C · FY2022 · HD
Interactive Parent-targeted Text Messaging in Pediatric Clinics to Reduce ECC
$1,158,855Belinda Borrelli · Boston University Medical Campus · UH3 · FY2019 · DE
Cellular Mechanisms Of Xenobiotic Transport
$1,158,379David Miller · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
An Adaptive Intervention Trial of Home Testing with Behavioral Nudges for Improving COVID-19 Testing and Prevention among People Affected by Diabetes
$1,156,661Mary Beth Weber · Emory University · U01 · FY2022 · DK
Autologous T-cells Expressing a Chimeric Antigen Receptor Directed to B-Cell Maturation Antigen (BCMA) in patients with Generalized Myasthenia Gravis (MG)
$1,154,358Metin Kurtoglu · Cartesian Therapeutics, Inc. · R44 · FY2021 · NS
Cellular Mechanisms Of Xenobiotic Transport
$1,153,051David Miller · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
CD19-Specific Central Memory T Cell Adoptive Immunotherapy for Non-Hodgkin Lymphoma
$1,152,253Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P50 · FY2014 · CA
A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies
$1,150,207Jing Zhou · Isoplexis, Inc. · R44 · FY2021 · CA
A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies
$1,150,207Jing Zhou · Isoplexis, Inc. · R44 · FY2020 · CA
Developing Novel Therapies for High Risk Pediatric Cancers
$1,148,695Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Collaborative Research: Expeditions in Computing: The Science of Deep Specification
$1,148,325Adam J Chlipala · Massachusetts Institute Of Technology · · FY2015 · CSE
SBIR Phase II: Smart Solar Control Film
$1,147,626Brian J Schultz · Dimien Inc. · · FY2015 · TIP